Here, we demonstrated for the first time that in vivo tumor growth could be reduced when the TMEs were devoid of CAFs which could be recruited and activated when RhoA/SF-aligned periFN was absent on tumor cell surfaces. The gene discussed is RHOA; the disease is neoplasm.